Estudio de extensión abierto del fármaco oral CEP-701 en pacientes con enfermedades malignas hematológicas y no hematológicas que han participado en un estudio clínico del CEP-701

Update Il y a 4 ans
Reference: EUCTR2005-005542-39

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the safety and tolerability of long term administration of CEP 701 in patients with advanced malignancy.


Inclusion criteria

  • Patients with hematologic and non hematologic malignancies who have participated in a clinical study of CEP 701 may participate in this extension study